tetano
Editor, Senior Moderator
Molecules. 2016 Aug 27;21(9). pii: E1138. doi: 10.3390/molecules21091138.
[h=1]Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza.[/h] Yang XY[SUP]1,[/SUP][SUP]2[/SUP], Liu AL[SUP]3[/SUP], Liu SJ[SUP]4[/SUP], Xu XW[SUP]5[/SUP], Huang LF[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] To screen for influenza virus neuraminidase inhibition and to provide a reference for the clinical treatment of influenza using traditional Chinese medicines (TCM). In this study, 421 crude extracts (solubilized with petroleum ether, ethanol, ethyl acetate, and aqueous solvents) were obtained from 113 TCM. The medicine extracts were then reacted with oseltamivir, using 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA) as the substrate, to determine influenza virus neuraminidase activity using a standard fluorimetric assay. It was found that Chinese medicine extracts from Pyrola calliantha, Cynanchum wilfordii, Balanophora involucrata and Paeonia delavayi significantly inhibited neuraminidase activity at a concentration of 40 μg/mL. Dose-dependent inhibitory assays also revealed significant inhibition. The IC50 range of the TCM extracts for influenza virus neuraminidase was approximately 12.66-34.85 μg/mL, respectively. Some Chinese medicines have clear anti-influenza viral effects that may play an important role in the treatment of influenza through the inhibition of viral neuraminidase. The results of this study demonstrated that plant medicines can serve as a useful source of neuraminidase (NA) inhibitors and further investigation into the pharmacologic activities of these extracts is warranted.
[h=4]KEYWORDS:[/h] neuraminidase inhibition; screening; traditional Chinese medicine
PMID: 27618892 DOI: 10.3390/molecules21091138
[PubMed - in process]
[h=1]Screening for Neuraminidase Inhibitory Activity in Traditional Chinese Medicines Used to Treat Influenza.[/h] Yang XY[SUP]1,[/SUP][SUP]2[/SUP], Liu AL[SUP]3[/SUP], Liu SJ[SUP]4[/SUP], Xu XW[SUP]5[/SUP], Huang LF[SUP]6[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] To screen for influenza virus neuraminidase inhibition and to provide a reference for the clinical treatment of influenza using traditional Chinese medicines (TCM). In this study, 421 crude extracts (solubilized with petroleum ether, ethanol, ethyl acetate, and aqueous solvents) were obtained from 113 TCM. The medicine extracts were then reacted with oseltamivir, using 2'-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA) as the substrate, to determine influenza virus neuraminidase activity using a standard fluorimetric assay. It was found that Chinese medicine extracts from Pyrola calliantha, Cynanchum wilfordii, Balanophora involucrata and Paeonia delavayi significantly inhibited neuraminidase activity at a concentration of 40 μg/mL. Dose-dependent inhibitory assays also revealed significant inhibition. The IC50 range of the TCM extracts for influenza virus neuraminidase was approximately 12.66-34.85 μg/mL, respectively. Some Chinese medicines have clear anti-influenza viral effects that may play an important role in the treatment of influenza through the inhibition of viral neuraminidase. The results of this study demonstrated that plant medicines can serve as a useful source of neuraminidase (NA) inhibitors and further investigation into the pharmacologic activities of these extracts is warranted.
[h=4]KEYWORDS:[/h] neuraminidase inhibition; screening; traditional Chinese medicine
PMID: 27618892 DOI: 10.3390/molecules21091138
[PubMed - in process]